Ken Griffin Idexx Laboratories Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$455.08 - $517.19 $4.37 Million - $4.97 Million	-9,600 Reduced 19.67%	39,200 $19.8 Million
Q2 2024 Aug 14, 2024	BUY	$468.04 - $548.53 $3.7 Million - $4.33 Million	7,900 Added 19.32%	48,800 $23.8 Million
Q1 2024 May 15, 2024	SELL	$515.08 - $576.87 $2.52 Million - $2.83 Million	-4,900 Reduced 10.7%	40,900 $22.1 Million
Q4 2023 Feb 14, 2024	BUY	$391.37 - $557.56 $6.97 Million - $9.92 Million	17,800 Added 63.57%	45,800 $25.4 Million
Q3 2023 Nov 14, 2023	BUY	$432.42 - $556.67 $2.94 Million - $3.79 Million	6,800 Added 32.08%	28,000 $12.2 Million
Q2 2023 Aug 14, 2023	SELL	$450.7 - $503.61 $33.2 Million - $37.1 Million	-73,600 Reduced 77.64%	21,200 $10.6 Million
Q1 2023 May 15, 2023	BUY	$406.01 - $514.59 $7.55 Million - $9.57 Million	18,600 Added 24.41%	94,800 $47.4 Million
Q4 2022 Feb 14, 2023	SELL	$324.64 - $441.27 $5.71 Million - $7.77 Million	-17,600 Reduced 18.76%	76,200 $31.1 Million
Q3 2022 Nov 14, 2022	BUY	$325.8 - $407.78 $9.22 Million - $11.5 Million	28,300 Added 43.21%	93,800 $30.6 Million

1,211

73.3M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $35.1B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.